Actavis CEO Says Health Law May Boost Generics Use

Feb. 15 (Bloomberg) -- Paul Bisaro, chief executive officer of Actavis Inc., talks about the impact of the U.S. Affordable Care Act on the pharmaceutical industry, so-called biosimilars, generic versions of biotechnology drugs, and the outlook for growth. He speaks with Mark Crumpton on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

Kyle Bass Warns of Huge Losses for Chinese Banks
49:20 - Albert Rabil, chief executive officer and managing partner at Kayne Anderson, discusses a warning by hedge fund manager Kyle Bass that China's banking system is at risk of losses that could top U.S. banks during the subprime crisis. He speaks on "Bloomberg ‹GO›." (Source: Bloomberg)
  • Private Equity Suffers Patient Capital Profit Pains
  • Why Can't Twitter Turnaround Monthly User Losses?
  • The Fine Line Between Leadership Success and Failure